#pharma #pharmaceuticals #NICE #desmoidtumours #NICEApproval #patientaccess #Merck #NICEfinaldraftguidance #Ogsiveo #England #NHS #CancerDrugsFund #nirogacestat #targeteddrugtreatment #rarecancer #softtissuetumours #DesmoidAidUK #DeFitrial #RareTumours #innovativemedicines
zurl.co/iM0Ds
zurl.co/iM0Ds
NICE backs first systemic therapy for desmoid tumours - PharmaTimes
Approval gives patients access to new targeted option
pharmatimes.com
October 5, 2026 at 10:10 AM